Diagnosis of hepatic steatosis in non-alcoholic fatty liver disease in the military
- Authors: Zhirkov II1
-
Affiliations:
- Военно-медицинская академия им. С.М. Кирова
- Issue: Vol 22, No 1 (2020)
- Pages: 100-104
- Section: Articles
- URL: https://ogarev-online.ru/1682-7392/article/view/25976
- DOI: https://doi.org/10.17816/brmma25976
- ID: 25976
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
I I Zhirkov
Военно-медицинская академия им. С.М. Кирова
Email: vmeda-nio@mil.ru
Санкт-Петербург
References
- Жирков, И.И. Хронические диффузные заболевания печени невирусной этиологии у военнослужащих / И.И. Жирков [и др.] // Вестн. Росс. воен.-мед. акад. - 2019. - № 4 (68). - С. 72-76.
- Ивашкин, В.Т. Распространенность неалкогольной жировой болезни печени у пациентов амбулаторно-поликлинической практики в Российской Федерации: результаты исследования DIREG 2 / В.Т. Ивашкин [и др.] // Росс. журн. гастроэнтерол. гепатол. колопроктол. - 2015. - № 6. - С. 31-41.
- Павлов, Ч.С. Биопсия и морфологическое исследование в диагностике хронических заболеваний печени различной этиологии / Ч.С. Павлов, В.Б. Золотаревский, В.Т. Ивашкин // Росc. журн. гастроэнтерол., гепатол. и колопроктол. - 2007. - Т. 19, № 1. - С. 90-94.
- Bedogni, G. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population / G. Bedogni [et al.] // BMC Gastroenterol. - 2006. - № 6. - P. 33.
- Bedossa, P. FLIP Pathology Consortium. Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease / P. Bedossa // Hepatology. - 2014. - Vol. 60. - P. 565-575.
- Bohn, M.J. The Alcohol Use Disorders Identification Test (AUDIT): validation of a screening instrument for use in medical settings / M.J. Bohn, T.F. Babor, H.R. Kranzler // J. Stud. Alcohol. - 1995. - Vol. 56, № 4. - P. 423-432.
- Chon, Y.E. Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population / Y.E. Chon [et al.] // Liver Int. - 2014. - Vol. 34, № 1. - P. 102-109.
- de Lédinghen, V. Noninvasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography / V. de Lédinghen [et al.] // Liver Int. 2012. - Vol. 32, № 6. - P. 911-918.
- EASL-EASD-EASO Clinical Practice Guideline for the management of non-alcoholic liver disease. European Association for the Study of the Liver (EASL) and European Association for the Study of Diabetes (EASD) and European Association for the Study of Obesity (EASO) // Diabetologia. - 2016. - Vol. 59. - P. 1121-1140.
- Kotronen, A. Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors / A. Kotronen [et al.] // Gastroenterology - 2009. - Vol. 137, № 3. - P. 865-872.
- Lee, J.H. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease / J.H. Lee [et al.] // Dig. Liver Dis. - 2010. - Vol. 42. - P. 503-508.
- Masaki, K. Utility of controlled attenuation parameter measurement for assessing liver steatosis in Japanese patients with chronic liver diseases / K. Masaki [et al.] // Hepatol. Res. - 2013. - Vol. 43, № 11. - P. 1182-1189.
- Poynard, T. The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis / T. Poynard [et al.] // Comp. Hepatol. - 2005. - Vol. 4. - Р. 1-10.
- Sasso, M. Controlled attenuation parameter (CAP): a novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes / M. Sasso [et al.] // Ultrasound Med. Biol. - 2010. - Vol. 36, № 11. - P. 1825-1835.
- Yoneda, M. Utility of controlled attenuation parameter measurement for assessing liver steatosis in Japanese patients with chronic liver disease / M. Yoneda // Hepatol. Res. - 2013. - Vol. 43, № 11. - P. 1125-1126.
- Younossi, Z.M. Global epidemiology of nonalcoholic fatty liver disease - meta-analytic assessment of prevalence, incidence, and outcomes / Z.M. Younossi [et al.] // Hepatology - 2016. - Vol. 63. - P. 73-84.
Supplementary files
